Krawczyk , Paweł. “Role of Molecular Examinations in Qualification to First Line Treatment With Erlotinib in NSCLC Patients Based on EUTARCstudy Results”. OncoReview 3, no. 1(9) (March 29, 2013): 26-33. Accessed July 4, 2024. https://journalsmededu.pl/index.php/OncoReview/article/view/332.